Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
Ted Rogers Chair in Heart Function Outcomes Dr. Douglas Lee leads new Heart-Brain Connection $3 million IMPACT Award project
Four unique educational events in October and December
Targeting heart failure in Indigenous communities
Our funded study reveals inequitable COVID-19 rates from the start
Share your science with colleagues at the Ted Rogers Centre for Heart Research’s 2023 Heart Failure Symposium.
We’re bringing together a multi-disciplinary community of researchers, clinicians, and engineers, to share the latest discoveries, insights, and innovations in cardiovascular science, with a focus on heart failure. You can expect an exciting scientific program highlighting ground-breaking collaborative research, interactive workshops, and networking opportunities, including a fun social hour.
This year, we’re exploring the theme Innovation Starts with Collaboration.
Abstract submissions and workshop proposals will be reviewed by an esteemed panel of experts. Be sure to check out the Call for Science Notice for more information on guidelines and key dates. Don’t miss this chance to make a significant impact in the field of heart research and level-up your career. Together we can drive progress and transform the future of cardiovascular health!
President, Sibel Health
Matthew is president of Sibel Health, a cutting-edge medtech company focused on commercializing wearable sensors for patients in both the hospital and home. Prior to this role, Matt founded toSense Inc.—purchased by Baxter in April 2020—and served as the company’s President and Chief Scientific Officer. In this capacity, Matt directed projects relating to fundraising, development of new hardware platforms and algorithms, intellectual property, sales/marketing, clinical studies, and regulatory. He was the driving force behind the company’s novel wearable medical device—the CoVaTM Necklace—the first-ever FDA-cleared wearable for measuring stroke volume, cardiac output, and fluids from patients suffering from congestive heart failure. Before toSense, Matt founded three successful companies before the age of 40, and all in different industries, and all resulting in a financial exit. His first, Active Impulse Systems, developed a novel optical measurement of metal films for the semiconductor industry, and was purchased by Philips Electronics. After that, Matt founded Networkcar (which later became NetworkFleet), a leader in automotive telematics that was ultimately purchased by Verizon Wireless. And after that, he founded Sotera Wireless, a San Diego-based medtech company marketing the first-ever FED-cleared wearable monitor for measuring all vital signs, and particularly cuffless blood pressure. Sotera was purchased by Foxconn in 2017.
Matt’s areas of expertise include the development of innovative physiological measurements; product design for medical devices; drafting/prosecuting intellectual property; and drafting/prosecuting regulatory filings. He received his Ph.D. from MIT (where he was the Institute’s Kodak Fellow) and his undergraduate degree from University of California, San Diego. He is a registered U.S. Patent Agent, and the named inventor on over 300 pending and issued patents. In his spare time, Matt enjoys playing fast-pitch baseball, golf, and exercising to keep his blood pressure (as measured by either cuffless or cuff-based technologies) as low as possible. With his wife, Candice, he has also owned a martini bar in Maui. He survived stage-3 cancer in 2018.